Skip to main content
OpenTrials

Clinical trial condition

Peritoneal Carcinoma

Explore clinical trials studying Peritoneal Carcinoma. Study availability and eligibility vary by location and protocol.

20 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Peritoneal Carcinoma trial results

Completed

Ribociclib (Ribociclib (LEE-011)) With Platinum-based Chemotherapy in Recurrent Platinum Sensitive Ovarian Cancer

NCT03056833

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
  • UPMC Hillman Cancer Center Upper St. Clair Bethel Park, Pennsylvania, United States
  • UPMC Hillman Cancer Center Arnold Palmer at Mountain View Greensburg, Pennsylvania, United States
  • UPMC Hillman Cancer Center Arnold Palmer Medical at Norwin Irwin, Pennsylvania, United States
View Trial Details
Completed

Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy

NCT03593681

Conditions
Abdominal Neoplasms, Adnexal Diseases, Adnexal Mass, +26 more
Locations
  • Scripps Clinic Medical Group San Diego, California, United States
  • Kaiser Permanente San Francisco Medical Center San Francisco, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Active, Not Recruiting

Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer

NCT05605535

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +18 more
Locations
  • Omega Hospitals Visakhapatnam, Andhra Pradesh, India
  • King George Hospital Visakhapatnam, Andhra Pradesh, India
  • Himalaya Cancer Hospital and Research Institute Vadodara, Gujarat, India
  • Kailash Cancer Hospital and Research Centre Vadodara, Gujarat, India
View all 14 locations
View Trial Details
Active, Not Recruiting

Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

NCT04498117

Conditions
Abdominal Neoplasms, Adnexal Diseases, Carcinoma, +29 more
Locations
  • Honor Health Phoenix, Arizona, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • John Muir Health Clinical Research Center Concord, California, United States
  • Kaiser Permanente Southern California Irvine, California, United States
View all 148 locations
View Trial Details

Related conditions